| Company: | Danaher Corporation |
|---|---|
| CEO: |
|
| Founded: | 1969 |
| Symbol: | DHR |
| Exchange: | NYSE |
| Industry: | Medical - Diagnostics & Research |
| Sector: | Healthcare |
| About |
Danaher Corporation is a diversified global technology and science company that specializes in developing, manufacturing, and distributing a wide array of professional, medical, industrial, and commercial products and services across the world. The organization is structured into three primary operating segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. Within the Life Sciences segment, Danaher provides advanced instrumentation and solutions crucial for scientific research and development. This encompasses equipment like mass spectrometers, flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization tools, and microscopes, alongside genomics consumables and technologies vital for Gene and Cell Therapy. Additionally, it delivers bioprocess technologies, consumables, and related services, as well as sophisticated filtration, separation, and purification systems. Its diverse clienteleludes pharmaceutical, biopharmaceutical, food and beverage, medical, and life sciences companies, in addition to universities, medical schools, research institutions, and various industrial manufacturers. The Diagnostics segment is dedicated to furnishing essential tools for healthcare. Its offerings range from comprehensive systems for chemistry, immunoassay, microbiology, and automation to products for hematology, molecular, acute care, and pathology diagnostics. This segment equips hospitals, physicians' offices, reference laboratories, and other critical care settings with clinical instruments, reagents, consumables, software, and support services for accurate patient diagnosis and management. The Environmental & Applied Solutions segment addresses a broad spectrum of industrial and resource management requirements. It supplies instrumentation, consumables, software, services, and disinfection systems critical for the analysis, treatment, and management of various water types—including ultra-pure, potable, industrial, waste, ground, source, and ocean water—across residential, commercial, industrial, and natural resource applications. Furthermore, this segment delivers instruments, software, services, and consumables tailored for color and appearance management, packaging design and quality assurance, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. Established in 1969, the company was initially known as Diversified Mortgage Investors, before officially rebranding as Danaher Corporation in 1984. Its corporate headquarters are located in Washington, D.C. |
13 among 2804 companies
2200 Pennsylvania Avenue, NW
Washington | DC |
US
| Danaher Corporation;DHR;https://bullfincher.io/logos/us/DHR.png;danaher-corporation | 24568000000.00 |
|---|---|
| Agilent Technologies;A;https://financialmodelingprep.com/image-stock/A.png;agilent-technologies | 6948000000.00 |
| Thermo Fisher Scientific;TMO;https://bullfincher.io/logos/us/TMO.png;thermo-fisher-scientific | 44556000000.00 |
Danaher Corporation was founded on 1969, which makes the company 57 years old.
Rainer Blair is the CEO of Danaher Corporation.
Danaher Corporation operates in the Medical - Diagnostics & Research industry and the Healthcare sector.
Danaher Corporation has 60,000 employees.
In fiscal year 2025, Danaher Corporation generated a revenue of $24.57 Billion.
In fiscal year 2025, Danaher Corporation reported a net income of $3.61 Billion.
Revenue from Contract with Customer, Measurement, Recurring is Danaher Corporation's biggest product segment, representing 81.92% of its total revenue.
Danaher Corporation went public on Dec 29, 1978, through its Initial Public Offering (IPO), and it has been 47 years since then.
Danaher Corporation's ticker symbol is DHR, and the company is listed on the NYSE stock market exchange.
Danaher Corporation's current stock price is $200.18 as of Jul 14, 2026.
Ranked #13among 2,804 companies based on market cap.
Competitors of Danaher Corporation include Agilent Technologies and Thermo Fisher Scientific, and more.